Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly?: Meta-analysis of >12,000 patients in large-scale clinical trials
Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly?: Meta-analysis of >12,000 patients in large-scale clinical trials
复制标题
DOI：
10.1016/j.amjcard.2004.11.052
复制
发表时间：
2005-04-01
影响因子：
2.8
通讯作者：
Krum, H
中科院分区：
文献类型：
--
作者：
Dulin, BR;Haas, SJ;Krum, H
对5项已完成的β受体阻滞剂试验中老年和非老年慢性心力衰竭患者的全因死亡率数据进行的荟萃分析显示，老年和非老年慢性心力衰竭患者从β受体阻滞剂治疗中获得了相当大的预后获益，两组之间的死亡率降低无统计学显著差异。(c)2005年，Excerpta Medica Inc.
A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart failure patients from 5 completed beta-blocker trials revealed that elderly and non-elderly chronic heart failure patients derived considerable prognostic benefit from beta-blacker therapy without a statistically significant difference in mortality reduction between the 2 groups. (c) 2005 by Excerpta Medica Inc.